Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case–cohort analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case–cohort analysis ; day:16 ; month:2 ; year:2024 ; pages:1-13
Cancer causes & control ; (16.2.2024), 1-13
- Urheber
-
Albers, Frances E. M.
Lou, Makayla W. C.
Dashti, S. Ghazaleh
Swain, Christopher T. V.
Rinaldi, Sabina
Viallon, Viviane
Karahalios, Amalia
Brown, Kristy A.
Gunter, Marc J.R.
Milne, Roger L.
English, Dallas R.
Lynch, Brigid M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10552-024-01856-6
- URN
-
urn:nbn:de:101:1-2404240900132.982589080527
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Albers, Frances E. M.
- Lou, Makayla W. C.
- Dashti, S. Ghazaleh
- Swain, Christopher T. V.
- Rinaldi, Sabina
- Viallon, Viviane
- Karahalios, Amalia
- Brown, Kristy A.
- Gunter, Marc J.R.
- Milne, Roger L.
- English, Dallas R.
- Lynch, Brigid M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients
The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2 −) advanced/metastatic breast cancer
Estrogen levels in young women with hormone receptor-positive breast cancer on ovarian function suppression therapy
Radioimmunoassay of steroid hormones
Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells
The tumour response of postmenopausal hormone receptor-positive breast cancers undergoing different types of neoadjuvant therapy: a meta-analysis
Rat Models of Hormone Receptor-Positive Breast Cancer
Synthesis of the Steroid Hormones
The impact of CBP expression in estrogen receptor-positive breast cancer
Patients’ preferences for postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treatments in Japan
HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women
The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer
CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients
The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2 −) advanced/metastatic breast cancer
Estrogen levels in young women with hormone receptor-positive breast cancer on ovarian function suppression therapy
Radioimmunoassay of steroid hormones
Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells
The tumour response of postmenopausal hormone receptor-positive breast cancers undergoing different types of neoadjuvant therapy: a meta-analysis
Rat Models of Hormone Receptor-Positive Breast Cancer
Synthesis of the Steroid Hormones
The impact of CBP expression in estrogen receptor-positive breast cancer
Patients’ preferences for postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treatments in Japan
HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women
The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer
CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients
The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2 −) advanced/metastatic breast cancer
Estrogen levels in young women with hormone receptor-positive breast cancer on ovarian function suppression therapy
Radioimmunoassay of steroid hormones
Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells
The tumour response of postmenopausal hormone receptor-positive breast cancers undergoing different types of neoadjuvant therapy: a meta-analysis
Rat Models of Hormone Receptor-Positive Breast Cancer
Synthesis of the Steroid Hormones
The impact of CBP expression in estrogen receptor-positive breast cancer
Patients’ preferences for postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treatments in Japan
HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women